Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Generation of Pulsatile Flow using Clinical Continuous Flow Pumps.JHLT open · 2024
   Review
2. Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device.International journal of molecular sciences · 2023
   Review
3. Effects of Pulsatility on Arterial Endothelial and Smooth Muscle Cells.Cells, tissues, organs · 2023
   Article
4. Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation.ESC heart failure · 2021
   Article
5. Novel Use of Tamoxifen to Reduce Recurrent Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices.Journal of cardiovascular translational research · 2021
   Article
6. Device-related epistaxis risk: continuous-flow left ventricular assist device-supported patients.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2020
   Article
7. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.Circulation research · 2019
   Review
8. Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2018
   Article

Corrections and comments

• Comment on
  Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding.2016

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.